Elanco Animal Health Management
Management criteria checks 3/4
Elanco Animal Health's CEO is Jeff Simmons, appointed in Jul 2018, has a tenure of 6.33 years. total yearly compensation is $13.66M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $14.92M. The average tenure of the management team and the board of directors is 5.9 years and 5.7 years respectively.
Key information
Jeff Simmons
Chief executive officer
US$13.7m
Total compensation
| CEO salary percentage | 8.8% |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | 5.9yrs |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals
Nov 15
Elanco Animal Health: Not Expensive, But Debt Remains An Issue
Nov 08Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden
Sep 22Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Sep 01Elanco Animal Health: Positioned For Success
Aug 16Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%
Jul 11Elanco Animal Health: Pipeline Concerns Appear Overblown
Jun 30Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet
Jun 06Elanco Animal Health: At Least Fully Valued After Rally
Jun 05Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price
Apr 22Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt
Feb 24Elanco Animal Health: A Solid Sale Addresses Leverage
Feb 09Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough
Jan 01Elanco Animal Health: Turning More Healthy
Dec 21Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?
Nov 09Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile
Oct 05Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load
Aug 02Elanco Animal Health: Seems Like A Decent Bet Right Now
Jul 25Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges
Jul 14There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues
Jun 09Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet
Feb 22Elanco Q4 2022 Earnings Preview
Feb 20Elanco's Tangible Equity Units: Living With The Worst Case
Dec 13We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt
Nov 08Elanco Q3 2022 Earnings Preview
Nov 07Elanco Animal Health: This 'Sick Dog' Should Recover
Oct 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$205m |
| Jun 30 2024 | n/a | n/a | -US$1b |
| Mar 31 2024 | n/a | n/a | -US$1b |
| Dec 31 2023 | US$14m | US$1m | -US$1b |
| Sep 30 2023 | n/a | n/a | -US$1b |
| Jun 30 2023 | n/a | n/a | -US$113m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$13m | US$1m | -US$78m |
| Sep 30 2022 | n/a | n/a | -US$132m |
| Jun 30 2022 | n/a | n/a | -US$171m |
| Mar 31 2022 | n/a | n/a | -US$371m |
| Dec 31 2021 | US$12m | US$1m | -US$483m |
| Sep 30 2021 | n/a | n/a | -US$698m |
| Jun 30 2021 | n/a | n/a | -US$729m |
| Mar 31 2021 | n/a | n/a | -US$572m |
| Dec 31 2020 | US$9m | US$1m | -US$574m |
| Sep 30 2020 | n/a | n/a | -US$246m |
| Jun 30 2020 | n/a | n/a | -US$101m |
| Mar 31 2020 | n/a | n/a | -US$13m |
| Dec 31 2019 | US$16m | US$1m | US$68m |
| Sep 30 2019 | n/a | n/a | US$94m |
| Jun 30 2019 | n/a | n/a | US$144m |
| Mar 31 2019 | n/a | n/a | US$45m |
| Dec 31 2018 | US$5m | US$775k | US$87m |
| Sep 30 2018 | n/a | n/a | -US$91m |
| Jun 30 2018 | n/a | n/a | -US$172m |
| Mar 31 2018 | n/a | n/a | -US$174m |
| Dec 31 2017 | US$5m | US$688k | -US$311m |
Compensation vs Market: Jeff's total compensation ($USD13.66M) is above average for companies of similar size in the US market ($USD7.97M).
Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Simmons (57 yo)
6.3yrs
Tenure
US$13,663,169
Compensation
Mr. Jeffrey N. Simmons, also known as Jeff, serves as President and Chief Executive Officer at Elanco Animal Health Incorporated since July 2018 and its Director since September 2018. Mr. Simmons serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.3yrs | US$13.66m | 0.23% $ 14.9m | |
| Executive VP & CFO | 6yrs | US$3.73m | 0.035% $ 2.3m | |
| Executive Vice President of Elanco International | 6.3yrs | US$2.65m | 0.022% $ 1.5m | |
| Executive Vice President of Research | 3.1yrs | US$3.68m | 0.0097% $ 635.6k | |
| Executive Vice President of Corporate Strategy & Market Development | 1.7yrs | US$2.19m | 0.017% $ 1.1m | |
| Senior VP & Chief Accounting Officer | 6.2yrs | no data | 0.0054% $ 357.9k | |
| Senior VP & Chief Information Officer | no data | no data | no data | |
| Executive Vice President of Human Resources | 5.8yrs | US$2.85m | 0.024% $ 1.5m | |
| Head of Investor Relations | no data | no data | no data | |
| Executive Vice President | 1.8yrs | no data | 0.0048% $ 316.5k | |
| Senior Vice President of Asia | no data | no data | no data | |
| Chief Medical Officer | no data | no data | no data |
5.9yrs
Average Tenure
53yo
Average Age
Experienced Management: ELAN's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.2yrs | US$13.66m | 0.23% $ 14.9m | |
| Independent Director | 3.9yrs | US$330.01k | 0.0061% $ 399.4k | |
| Independent Director | 6.2yrs | US$496.01k | 0.060% $ 3.9m | |
| Independent Director | 3.9yrs | US$330.01k | 0.0020% $ 132.9k | |
| Independent Chairman | 6.2yrs | US$350.01k | 0.0020% $ 132.9k | |
| Independent Director | 5.5yrs | US$330.01k | 0.00071% $ 46.7k | |
| Independent Director | 5.7yrs | US$330.01k | no data | |
| Independent Director | 5.7yrs | US$346.01k | 0.0084% $ 555.3k | |
| Independent Director | 5.7yrs | US$346.01k | 0.00020% $ 13.2k | |
| Independent Director | 5.7yrs | US$330.01k | no data | |
| Independent Director | 6.2yrs | US$330.01k | 0.0040% $ 260.6k | |
| Independent Director | 6.2yrs | US$355.01k | 0.00065% $ 42.8k |
5.7yrs
Average Tenure
65.5yo
Average Age
Experienced Board: ELAN's board of directors are considered experienced (5.7 years average tenure).